Methadone is used to treat severe pain and to help people stop using heroin or other opioids by reducing cravings and withdrawal symptoms.[2] Dolophine is currently approved and in use across 30 indications[4].[1]
Dolophine is one of 494 small molecule programs targeting Cancer Pain. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
FDA Applications
NDA/BLA/ANDA regulatory filings
Pipeline
Competition
172 competitors in Chronic Kidney Disease
Dolophine
Uloric
Sovaldi
Glucotrol
Vemlidy
Lorelco
Activase
Flomax
PROCRIT
Verquvo
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Regulatory
Jan 1, 1982
METHADOSE
NDA NDA017116
Jan 1, 1982
METHADONE HYDROCHLORIDE
NDA NDA021624
Jan 1, 1982
METHADONE HYDROCHLORIDE
NDA NDA006383
Jan 1, 1982
DOLOPHINE HYDROCHLORIDE
NDA NDA006134
Jan 1, 1982
WESTADONE
NDA NDA017108
Jan 1, 1982
METHADONE HYDROCHLORIDE
NDA NDA017058
Sources
Details